Skip to content

Zymeworks ZYME Deferred Taxes

Deferred Taxes at other companies

Pfizer logo
PfizerPFE
-$12M+98.2%
Amgen logo
AmgenAMGN
-$176M+29.6%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$0+100%
TG Therapeutics logo
TG TherapeuticsTGTX
$3.86M
Charles River Laboratories logo
Charles River LaboratoriesCRL
-$29.42M-54.5%
TEC
Bio-TechneTECH
$2.84M+153%

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.79B+125%

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDeferredIncomeTaxes.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's deferred taxes?
Zymeworks (ZYME) reported deferred taxes of $2.2M in Q1 2026.
How has Zymeworks's deferred taxes changed year-over-year?
Zymeworks's deferred taxes increased by 436.6% year-over-year, from $410K to $2.2M.
What is the long-term trend for Zymeworks's deferred taxes?
Over 2 years (2023 to 2025), Zymeworks's deferred taxes has grown at a 11.7% compound annual growth rate (CAGR), from $757K to -$945K.
What does deferred taxes mean?
Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.